Ryverna Solution for Infusion
Marketer
Novartis India Ltd
Salt Composition
Crizanlizumab (10mg/ml)
Uses of Ryverna Solution for Infusion
Drepanocytosis
Major Benefits of Ryverna Solution for Infusion:
This medication will be administered by your physician or registered nurse; please refrain from self-medicating.
Common Side effects of Ryverna Solution for Infusion:
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Upper respiratory tract infection
- Rash
- Flu
- Dermatitis
- Bronchitis (inflammation of the airways)
- Eczema
- Swelling of lymph nodes
- Oropharyngeal pain
How to use Ryverna Solution for Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ryverna Solution for Infusion works:
Ryverna Infusion Solution acts by targeting P-selectin, a protein responsible for blood cell aggregation. Inhibiting this protein's function prevents blood cell clumping and adhesion to vessel walls, thereby enhancing systemic circulation. This mechanism reduces the likelihood of painful crises and other serious sickle cell disease sequelae, including stroke and end-organ damage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ryverna Infusion Solution hasn't been established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Ryverna Infusion Solution during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Ryverna Infusion Solution with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Ryverna Infusion Solution on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Ryverna Solution for Infusion use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Ryverna Solution for Infusion in patients suffering from hepatic impairment. Physician consultation is advised.
What if you forget to take Ryverna Solution for Infusion :
NA
Facts to Know About Ryverna Solution for Infusion
| Label | Value |
|---|---|
| Chemical Category | Short chains of amino acids |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Action Category | Monoclonal antibody therapy |
3,018 People bought this recently